Partner Content Partner Content People with Chronic Conditions Concerned About “Returning to... People living with chronic conditions remain cautious
Events Partner Content Real-World Evidence 2020: Rare Diseases and Innovative Thera... Explore practical applications of RWE in rare diseases
Partner Content Partner Content PatchAi startup now in the market to support patients and cl... Healthware Ventures invested in PatchAi
Partner Content Partner Content Invitation to SMI’s Orphan Drugs & Rare Diseases Conference ... SMi reports: Invitation from conference co-chair released for the 9th Annual Orphan Drugs & Rare Diseases conference, taking place in London this October
Partner Content Partner Content Pre-Filled Syringes - Chemical Compatibility and Design Stra... Insight in Pre-Filled Syringe Deisgn
News J&J scores EU approval for Tecvayli combo in second line Johnson & Johnson's multiple myeloma regimen is now approved as a second line treatment in both the US and the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
